SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 198.67+2.0%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Hippieslayer who wrote (16762)3/7/1998 11:44:00 PM
From: Henry Niman  Read Replies (1) of 32384
 
FUGAZI, They have an oral substitutes with increased specificity (the one reported at the meetings distinguish human and mouse G-CSF receptors). They can make and screen analogs quickly and cheaply to make even better drugs. It's call Targeted Drug Design and LGND has clearly defined the target and ways of making very cheap and effective bullets.

PS: A special thank you to our resident nay sayer. He has enticed interested parties to come forward with detailed explanations of the material presented at Keystone and Lake Tahoe.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News